BOSTON and INDIANAPOLIS, May 3, 2023 /PRNewswire/ — Genezen, a leading gene and cell therapy contract development and manufacturing organization (CDMO) today announced a poster presentation at the 26th Annual American Society for Gene and Cell Therapy (ASGCT) Conference in Los Angeles in May – highlighting the results of its…Read More
Genezen Announces Presentation at 2023 Annual Meeting of the American Society of Gene and Cell Therapy
